Greenshoe Option

The greenshoe option, formally known as the over-allotment option, grants the lead underwriter the right to sell up to 15% more shares than the original offering size. In a 10 million-share IPO, the underwriter allocates 11.5 million shares to investors and holds a short position of 1.5 million shares at the time of listing. The name traces back to the 1960 IPO of Green Shoe Manufacturing Company (now Stride Rite), the first deal to contractually codify this mechanism.

The elegance of the structure lies in its asymmetric payoff profile, which automatically adjusts to post-listing price action. If the stock falls below the IPO price, the underwriter enters the market as a buyer, covering the short position through open-market purchases. This buying pressure creates a natural price floor and signals demand to other market participants. If the stock trades above the IPO price, the underwriter exercises the option against the issuer, receiving freshly issued shares at the IPO price to close the short, and the issuer receives up to 15% more proceeds than originally planned.

In practice, the greenshoe is almost universally included in large IPOs across global markets. In the U.S., the SEC's Regulation M governs stabilizing bids, requiring public disclosure and capping the stabilization price at the offering price. In Korea, the Financial Investment Business Regulation limits the stabilization window to 30 days post-listing. For landmark Korean IPOs such as LG Energy Solution (2022), where first-day volatility was severe given the ₩12.75 trillion offering size, the syndicate exercised the full 15% over-allotment to manage price discovery during the critical early trading period.

Consider a concrete example: an IPO priced at ₩50,000 per share with a base offering of 10 million shares and a greenshoe of 1.5 million shares (15%). The stabilizing manager operates a dedicated account for 30 days post-listing. If the stock drifts to ₩47,000 on day two, the stabilizing manager begins purchasing shares in the open market at or below ₩50,000. If the stock averages ₩47,000 throughout the stabilization window and the manager buys all 1.5 million shares at that level, the stabilization account generates approximately ₩4.5 billion in profit (the difference between the ₩50,000 short proceeds received at IPO and the ₩47,000 average cost of covering). This profit is typically returned to the issuer or shared with the syndicate per the underwriting agreement.

In the bullish scenario, if the stock immediately jumps to ₩60,000 and stays there, the stabilizing manager never buys in the open market. Instead, on or before day 30, the manager exercises the greenshoe option against the issuer, receiving 1.5 million new shares at ₩50,000 each (raising an additional ₩75 billion for the issuer) to close the short position. The manager captures the difference between the ₩60,000 market price and ₩50,000 exercise price — though in practice, most underwriting agreements require this spread to be shared with selling shareholders or returned to the deal economics. Real-world stabilizations typically land somewhere in between, with partial open-market purchases combined with partial option exercise depending on the stock's trading path.

From a regulatory standpoint, stabilization bids are one of the few legally permitted forms of price manipulation. The SEC (in the U.S.) and FSS (in Korea) require public disclosure of the stabilization arrangement in the prospectus, strict record-keeping of all stabilizing transactions, and a hard cap on stabilization at the offering price. These guardrails ensure that greenshoe serves its intended purpose — orderly price discovery — rather than artificially inflating a stock above its fair value. Investors who understand the mechanism can use the presence or absence of stabilization activity as a signal about how the broader market is absorbing the new float.

For the issuer, the greenshoe is simultaneously a capital-raising upside and an implicit signal about demand quality. When the option is exercised in full, the issuer receives 15% more proceeds at the IPO price — a meaningful upside for large transactions. In LG Energy Solution's 2022 IPO, the full greenshoe exercise generated an additional roughly ₩1.9 trillion in proceeds. However, if stabilization buying is required throughout the 30-day window, management must contend with the uncomfortable reality that the market cleared below the offering price — raising questions about whether the deal was priced too aggressively. Structurally, issuers must also decide whether the greenshoe shares will come from new issuance (dilutive to existing holders) or from selling shareholders contributing additional secondary shares (non-dilutive to the company but impacting seller proceeds).

Institutional investors treat the presence and structure of the greenshoe as an important input to their IPO investment framework. A well-structured greenshoe signals that the underwriter has skin in the game for post-listing performance, which distinguishes quality bookrunners from those who simply price the deal and move on. For long-only funds that receive large allocations, the 30-day stabilization window provides a degree of downside protection during the critical period when lock-up holders cannot sell and retail sentiment often drives outsized volatility. Conversely, hedge funds and arbitrageurs sometimes trade around the anticipated end of the stabilization window, anticipating that buying support will withdraw and any excess demand will need to re-equilibrate.

For the underwriter, the greenshoe is the cornerstone of underwriting risk management. The moment the IPO is priced and the allotment letters go out, the lead bookrunner has effectively bought 115% of the offering from the issuer and sold it to investors. If the stock immediately collapses, the stabilization account — funded by the extra 15% over-allotment proceeds — provides a war chest to buy shares and defend the price without tapping the underwriter's own balance sheet. This asymmetric structure means the greenshoe essentially converts the underwriter's potential loss from a weakly performing IPO into a smaller, bounded stabilization cost. In exchange for bearing this residual risk, investment banks command underwriting fees typically ranging from 3.5% to 7% of proceeds on large ECM transactions, with the greenshoe being a key component of the risk-adjusted return on that fee.